Privacy metrics have emerged as a key measure to improve privacy program performance and maturity in terms of customer trust, risk mitigation, and business enablement.
This paper argues that traditional privacy law has a great deal to learn from the guidelines for informed consent that applies in federally funded biomedical and behavioral research.